Literature DB >> 28456620

Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease.

Fernando Sergio Leitao Filho1, Seung Won Ra2, Andre Mattman3, Robert S Schellenberg4, Nick Fishbane4, Gerard J Criner5, Prescott G Woodruff6, Stephen C Lazarus6, Richard Albert7, John E Connett8, Meilan K Han9, Fernando J Martinez10, Janice M Leung4, S F Paul Man4, Shawn D Aaron11, Robert M Reed12, Don D Sin13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28456620     DOI： 10.1016/j.jaci.2017.01.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.

Authors:  Hyun Lee; Cara Kovacs; Andre Mattman; Zsuzsanna Hollander; Virginia Chen; Raymond Ng; Janice M Leung; Don D Sin
Journal:  Respir Res       Date:  2022-05-31

2.  Adult Primary Antibody Deficiencies and the Lung.

Authors:  Ebru Damadoğlu
Journal:  Turk Thorac J       Date:  2021-05

3.  Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.

Authors:  Fernando Sergio Leitao Filho; Seung Won Ra; Andre Mattman; Robert S Schellenberg; Gerard J Criner; Prescott G Woodruff; Stephen C Lazarus; Richard Albert; John E Connett; Meilan K Han; Fernando J Martinez; Janice M Leung; S F Paul Man; Shawn D Aaron; Robert M Reed; Don D Sin
Journal:  Respir Res       Date:  2018-02-14

4.  Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.

Authors:  Juthaporn Cowan; Sunita Mulpuru; Shawn Aaron; Gonzalo Alvarez; Antonio Giulivi; Vicente Corrales-Medina; Venkatesh Thiruganasambandamoorthy; Kednapa Thavorn; Ranjeeta Mallick; D William Cameron
Journal:  Pilot Feasibility Stud       Date:  2018-08-11

5.  Serum IgG Concentrations in Adult Patients Experiencing Virus-Induced Severe Asthma Exacerbations.

Authors:  Morgane Verduyn; Guillaume Botto; Julien Jaubert; Clément Lier; Thomas Flament; Laurent Guilleminault
Journal:  J Allergy Clin Immunol Pract       Date:  2019-01-14

6.  Hypogammaglobulinemia and Risk of Exacerbation and Mortality in Patients with COPD.

Authors:  Are M Holm; Siw L Andreassen; Vivi Lycke Christensen; Johny Kongerud; Øystein Almås; Henrik Auråen; Anne H Henriksen; Ingeborg S Aaberge; Olav Klingenberg; Tone Rustøen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-16

Review 7.  Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations.

Authors:  Dana Unninayar; Sara J Abdallah; D William Cameron; Juthaporn Cowan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-02

8.  Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.

Authors:  Severin Vogt; Jörg D Leuppi; Jonas Rutishauser; Michael Osthoff; Philipp Schuetz; Beat Mueller; Carmen Volken; Sarah Dräger; Marten Trendelenburg
Journal:  Respir Res       Date:  2021-08-14

9.  A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.

Authors:  Juthaporn Cowan; Sunita Mulpuru; Sara J Abdallah; Anchal Chopra; Andrew Purssell; Michaeline McGuinty; Gonzalo G Alvarez; Antonio Giulivi; Vicente Corrales-Medina; Derek MacFadden; Loree Boyle; Delvina Hasimja; Kednapa Thavorn; Ranjeeta Mallick; Shawn D Aaron; D William Cameron
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.